Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro.

Sheng M, Zhong Y, Chen Y, Du J, Ju X, Zhao C, Zhang G, Zhang L, Liu K, Yang N, Xie P, Li D, Zhang MQ, Jiang C.

Sci China Life Sci. 2014 Oct;57(10):959-72. doi: 10.1007/s11427-014-4742-y. Epub 2014 Sep 13.

PMID:
25218824
2.

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.

Iampietro M, Younan P, Nishida A, Dutta M, Lubaki NM, Santos RI, Koup RA, Katze MG, Bukreyev A.

PLoS Pathog. 2017 May 22;13(5):e1006397. doi: 10.1371/journal.ppat.1006397. eCollection 2017 May.

3.

Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.

Zhang X, Ao Z, Bello A, Ran X, Liu S, Wigle J, Kobinger G, Yao X.

Antiviral Res. 2016 Mar;127:20-31. doi: 10.1016/j.antiviral.2016.01.001. Epub 2016 Jan 9.

PMID:
26778707
4.

Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.

Usami K, Matsuno K, Igarashi M, Denda-Nagai K, Takada A, Irimura T.

Biochem Biophys Res Commun. 2011 Apr 1;407(1):74-8. doi: 10.1016/j.bbrc.2011.02.110. Epub 2011 Mar 6.

PMID:
21362405
5.

The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.

Marzi A, Akhavan A, Simmons G, Gramberg T, Hofmann H, Bates P, Lingappa VR, Pöhlmann S.

J Virol. 2006 Jul;80(13):6305-17.

6.

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY.

J Virol. 2006 Mar;80(6):2738-46.

7.

Inhibition of hsa-miR-6086 protects human umbilical vein endothelial cells against TNFα-induced proliferation inhibition and apoptosis via CDH5.

Cai X, Zhou X, Xiao F, Ye B, Huang W, Huang Z.

Gene. 2018 Jun 30;661:202-208. doi: 10.1016/j.gene.2018.03.091. Epub 2018 Mar 29.

PMID:
29605606
8.

Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.

Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, Bates P.

PLoS Pathog. 2010 Sep 9;6(9):e1001098. doi: 10.1371/journal.ppat.1001098.

9.

Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles.

Li H, Yu F, Xia S, Yu Y, Wang Q, Lv M, Wang Y, Jiang S, Lu L.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02168-16. doi: 10.1128/AAC.02168-16. Print 2017 Apr.

10.

Identification of Ebola virus microRNAs and their putative pathological function.

Liang H, Zhou Z, Zhang S, Zen K, Chen X, Zhang C.

Sci China Life Sci. 2014 Oct;57(10):973-81. doi: 10.1007/s11427-014-4759-2. Epub 2014 Sep 29.

PMID:
25266153
11.

MicroRNA-513a-5p mediates TNF-α and LPS induced apoptosis via downregulation of X-linked inhibitor of apoptotic protein in endothelial cells.

Shin S, Moon KC, Park KU, Ha E.

Biochimie. 2012 Jun;94(6):1431-6. doi: 10.1016/j.biochi.2012.03.023. Epub 2012 Apr 5.

PMID:
22504158
12.

Anti-Ebola MAb 17A3 reacts with bovine and human alpha-2-macroglobulin proteins.

Yu JS, Ma BJ, Scearce RM, Liao HX, Haynes BF.

J Virol Methods. 2010 Sep;168(1-2):248-50. doi: 10.1016/j.jviromet.2010.04.025. Epub 2010 May 4.

13.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
14.

Functionally orthologous viral and cellular microRNAs studied by a novel dual-fluorescent reporter system.

You X, Zhang Z, Fan J, Cui Z, Zhang XE.

PLoS One. 2012;7(4):e36157. doi: 10.1371/journal.pone.0036157. Epub 2012 Apr 27.

15.

Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.

Alazard-Dany N, Volchkova V, Reynard O, Carbonnelle C, Dolnik O, Ottmann M, Khromykh A, Volchkov VE.

J Gen Virol. 2006 May;87(Pt 5):1247-57.

PMID:
16603527
16.

MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.

Hoss AG, Kartha VK, Dong X, Latourelle JC, Dumitriu A, Hadzi TC, Macdonald ME, Gusella JF, Akbarian S, Chen JF, Weng Z, Myers RH.

PLoS Genet. 2014 Feb 27;10(2):e1004188. doi: 10.1371/journal.pgen.1004188. eCollection 2014 Feb.

17.

Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway.

Sullivan NJ, Peterson M, Yang ZY, Kong WP, Duckers H, Nabel E, Nabel GJ.

J Virol. 2005 Jan;79(1):547-53.

18.

Cell-cell contact promotes Ebola virus GP-mediated infection.

Miao C, Li M, Zheng YM, Cohen FS, Liu SL.

Virology. 2016 Jan 15;488:202-15. doi: 10.1016/j.virol.2015.11.019. Epub 2015 Dec 3.

19.

Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.

Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE.

Am J Pathol. 2003 Dec;163(6):2371-82.

20.

MicroRNA 299-3p modulates replicative senescence in endothelial cells.

Jong HL, Mustafa MR, Vanhoutte PM, AbuBakar S, Wong PF.

Physiol Genomics. 2013 Apr 1;45(7):256-67. doi: 10.1152/physiolgenomics.00071.2012. Epub 2013 Jan 29.

PMID:
23362143

Supplemental Content

Support Center